CUAMC
RXDX

China Universal Asset Management Company’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

China Universal Asset Management Company’s Portfolio RXDX Stock Details RXDX Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-644
Closed -$69.1K – 464
2023
Q1 		$69.1K Buy
644
+218
+51% +$23.4K 0.02% 143
2022
Q4 		$46.9K Buy
426
+43
+11% +$4.73K 0.02% 139
2022
Q3 		$23K Buy
+383
New +$23K 0.01% 149